Publisher
Springer Science and Business Media LLC
Reference88 articles.
1. • Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, et al. Epidemiology of renal cell carcinoma. Eur Urol [Internet]. 2019;75:74–84. Available from: https://doi.org/10.1016/j.eururo.2018.08.036. A comprehensive and updated review of the epidemiology, including risk factors, of the renal cell carcinoma.
2. Campbell SC, Lane BR, Pierorazio PM. Malignant renal tumors. In: Partin A, Dmochowski RR, Kavoussi L, Peters C, editors. Campbell-Walsh-Wein Urology. 12th ed. Filadélfia: Elsevier; 2021. p. 2133–84.
3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin [Internet]. 2021;71:209–49. Available from: https://onlinelibrary.wiley.com/doi/10.3322/caac.21660.
4. Snyder ME, Bach A, Kattan MW, Raj G V., Reuter VE, Russo P. Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol [Internet]. 2006;176:2391–6. Available from: http://www.jurology.com/doi/10.1016/j.juro.2006.08.013.
5. Howlader N, Noone A-M, Krapcho M, Miller D, Brest A, Yu M, et al. SEER Cancer Statistics Review, 1975–2018, National Cancer Institute [Internet]. Bethesda, MD; 2021. Available from: https://seer.cancer.gov/csr/1975_2018/.